SCHEMBL19634161

SCHEMBL19634161

COc1ccc(CN(Sc2ccc(N)c(C)c2)c2cscn2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.34
QPCT Q16769 1/20 0.33
LMNA P02545 3/20 0.32
POLB P06746 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
TSPO P30536 1/20 0.32
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
PTGIR P43119 1/20 0.31
TSHR P16473 2/20 0.31
CYP1A2 P05177 1/20 0.31
CHRM2 P08172 1/20 0.31
CYP3A4 P08684 1/20 0.31
HTR1A P08908 1/20 0.31
ADRA2A P08913 1/20 0.31
CYP2D6 P10635 1/20 0.31
DRD1 P21728 1/20 0.31
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21794109 0.85 ALDH1A1 (0.34) ALDH1A1LMNAPOLBSMN1; SMN2TSPO
SCHEMBL19634264 0.78 GCK (0.33) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL19631718 0.76 MMP9 (0.44) ALDH1A1LMNASMN1; SMN2
SCHEMBL21783460 0.75 ALDH1A1 (0.34) ALDH1A1LMNAPOLBSMN1; SMN2TSPO
SCHEMBL19634192 0.74 APLNR (0.34) ALDH1A1QPCTLMNAMEN1KMT2A
SCHEMBL21773016 0.72 CNR2 (0.42) ALDH1A1LMNAAPLNR
SCHEMBL21794068 0.72 APLNR (0.34) ALDH1A1LMNASMN1; SMN2MEN1KMT2A
SCHEMBL19634304 0.72 ACLY (0.35) ALDH1A1QPCTLMNASMN1; SMN2MEN1
SCHEMBL21793990 0.71 ACLY (0.35) ALDH1A1LMNAMEN1KMT2AMAPK1
SCHEMBL19634076 0.70 APLNR (0.32) ALDH1A1QPCTLMNATSPONPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017201468-A1 BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2017-11-23 WO disclosed